Buteyko method.

The Buteyko method was developed by Soviet physician Konstantin Buteyko in the 1950s as a treatment for asthma. His core thesis: chronic over-breathing — taking more breaths and bigger breaths than the body actually needs — is the upstream cause of a wide range of symptoms, and deliberately reducing breath volume retrains CO2 tolerance and improves multiple downstream outcomes.

The clinical evidence in asthma is real but narrower than the thesis. Randomized trials show less reliever-inhaler use and, in some, fewer symptoms — without measurable change in lung function. Beyond asthma — anxiety, sleep, athletic performance — it is largely untested. The technique overlaps with HRV-focused practice in form, and it’s worth understanding even if you’re not asthmatic.

The core protocol

Buteyko practice is built around three principles: nasal breathing always, light breathing rather than deep, and deliberate breath-holds to raise CO2 tolerance.

The Control Pause (CP).The diagnostic measurement in Buteyko practice. Sit upright. Exhale normally. Pinch your nose closed. Time how long until you feel the first definite urge to breathe — not the “maximum hold time,” just the first clear signal. Release. Resume normal nasal breathing. The number of seconds is your CP.

Buteyko teaching reads a longer CP as better CO2 tolerance and claims that raising it through daily practice produces health improvements. The premise under that number has been tested, and it failed: in a study of 83 adults, breath-hold time did not predict resting end-tidal CO2. The correlation ran the opposite way to Buteyko’s claim. The same study found breath-hold time did track breathing pattern in people with abnormal spirometry, so the CP measures something — just not what the method says it does.

Reduced breathing exercises.The training protocol. Sit comfortably. Breathe through the nose, but deliberately smaller than normal — less air per breath, fewer breaths per minute. The target is a slight, sustained “air hunger” — feeling like you’re not getting enough air, but never to the point of strain. Continue for 5–10 minutes. Repeat several times per day.

Mouth taping at night. Some Buteyko practitioners advocate taping the mouth closed during sleep to enforce nasal breathing. A 2025 systematic review of ten studies (213 patients) found two with improvements in sleep-apnea markers, others with no difference, and reported potential risks including asphyxiation when the nose is obstructed. Its authors conclude that indiscriminate mouth taping carries a potentially serious risk of harm. If you snore, have sleep apnea, or can’t breathe freely through your nose, don’t tape without a physician’s say-so.

The CO2 tolerance argument

The Buteyko mechanism centers on CO2 chemistry. Buteyko’s claim is that most adults slightly over-breathe — exhaling CO2 faster than they produce it — and so live with arterial CO2 below the physiological optimum.

He leaned on real chemistry to make the case: lower CO2 makes hemoglobin hold oxygen more tightly (the Bohr effect), so, the argument goes, over-breathing moves more air while delivering less oxygen to tissue. The contested steps are the diagnosis (that ordinary adults are chronically low on CO2) and the fix (that reduced-breathing exercises raise it).

The asthma trials don’t support the fix. In the 1998 Australian trial, Buteyko practice lowered resting minute ventilation, but end-tidal CO2 — low in both groups at the start — did not change with treatment. Whatever the method does for asthma, the data don’t show it doing it by raising CO2.

What the evidence shows

Asthma. The randomized trials show a consistent pattern: less reliever medication, sometimes fewer symptoms, no change in lung function. In Bowler et al. (1998), 39 people with asthma who practised Buteyko cut their daily reliever (beta2-agonist) dose far more than controls over three months, with no change in peak flow or FEV1. In Cowie et al. (2008), Buteyko and physiotherapist-taught breathing improved asthma control about equally, with lower inhaled-steroid use in the Buteyko group.

The 2020 Cochrane review of breathing exercises for adult asthma pooled 22 studies, only two of which involved Buteyko. It concludes that breathing exercises may have some positive effects on quality of life, hyperventilation symptoms and lung function, with the certainty of evidence ranging from moderate to very low. Buteyko is an add-on to prescribed asthma treatment in these trials, never a replacement for it.

Anxiety, panic, sleep, athletic performance. We could not find randomized trials of the Buteyko method itself in any of these uses worth citing. The case for them rests on the CO2 argument above — the part that failed its test. Patrick McKeown, the method’s most prominent modern proponent, has popularized the endurance-athlete application. Treat all of these as hypotheses.

Where Buteyko overlaps with HRV practice

The methods overlap in form. Both emphasize nasal breathing. Both slow the breath down. Both are daily practices rather than one-off fixes.

The difference is the target. Buteyko targets breath volume and CO2 tolerance and tracks the Control Pause. Resonance breathing targets a specific slow rate and is tracked with HRV. Whether training one moves the other’s number is not something we have found a trial for. They are compatible, not competing.

When Buteyko is the right pick over resonance

• Asthma.The only use with a trial evidence base — as an add-on to prescribed treatment, with your asthma physician in the loop. The trials measured reliever use going down, not lung function going up.
• Habitual mouth breather. If you breathe through your mouth much of the day and want to switch to nasal breathing, Buteyko provides a structured protocol for the transition.

For HRV-focused practice in non-asthmatic adults, resonance breathing is the protocol with the HRV literature behind it. For asthma, as an add-on, Buteyko is a legitimate primary protocol.

Why HRV Breathe doesn’t include Buteyko

The Buteyko protocol requires the deliberate air-hunger sensation that’s central to its training stimulus. That’s difficult to deliver through a visual breath pacer — the pacer can’t enforce light breathing, only slow breathing. The methods need a different teaching model than the one HRV Breathe uses.

If you’re interested in Buteyko specifically, Patrick McKeown’s book The Oxygen Advantageis the most accessible modern treatment. The Buteyko Clinic International runs structured online courses. It can sit alongside daily resonance breathing in HRV Breathe; the two don’t compete for the same slot.